Luteolin

규격

491-70-3CAS 번호

207-741-0EC 번호

2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromen-4-oneIUPAC 명칭

C15H10O6화학식

286.24 g/mol분자량

luteolin; 491-70-3; 3',4',5,7-Tetrahydroxyflavone; Digitoflavone; Luteolol; Luteoline; 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4H-chromen-4-one; Flacitran; Salifazide; Yama kariyasu; Weld Lake; 5,7,3',4'-Tetrahydroxyflavone; Cyanidenon-1470; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromen-4-one; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-; 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-benzopyrone; KUX1ZNC9J2; DTXSID4074988; CHEBI:15864; 3',4',5,7-Tetrahydroxy-Flavone; RefChem:6458; DTXCID6040668; 207-741-0; Cyanidenon 1470; Bismite; Luteolin (Standard); MFCD00017309; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one; CHEMBL151; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chromen-4-one; FLAVONE, 3',4',5,7-TETRAHYDROXY-; 1318-21-4; C.I. Natural Yellow 2; SMR000326896; 7-Tetrahydroxyflavone; CCRIS 3790; SR-01000779333; EINECS 207-741-0; UNII-KUX1ZNC9J2; BRN 0292084; Luteoin; Daphneflavonol;; Digitoflavone;; Lutl; Flavopurpol;; Luteolin?; C.I. 75590; 4dew; 4dgn; 4hkn; LU2; Luteoline(Standard); Prestwick_122; DIOSMETIN_met006; LUTEOLIN [MI]; Prestwick0_000870; Prestwick1_000870; Prestwick2_000870; Prestwick3_000870; Epitope ID:613439; LUTEOLIN [WHO-DD]; BIDD:PXR0059; Lopac0_000660; Oprea1_849964; SCHEMBL20426; BSPBio_000919; Luteolin, analytical standard; MLS000697655; MLS000860038; MLS002154043; MLS006011917; BIDD:ER0122; SPBio_002840; BDBM7459; BPBio1_001011; GTPL5215; MEGxp0_000143; orb1310014; orb3140399; SCHEMBL29352380; SCHEMBL29376494; SCHEMBL30045580; ACon1_000223; cid_5280445; HY-N0162R; GLXC-06558; HMS1570N21; HMS2097N21; HMS2220C06; HMS3356L02; HMS3561N09; HMS3649N21; HMS3656A05; HMS3714N21; HMS5080H10; Luteolin, >=99.0% (TLC); HY-N0162; MSK40243; TNP00073; Luteolin, >=98% (TLC), powder; BBL027837; EBC-11086; LMPK12110006; s2320; SBB066117; STK801923; AKOS002140588; AC-1125; CCG-208309; CS-4611; DB15584; FL24959; KS-5202; Luteolin 100 microg/mL in Acetonitrile; SMP2_000042; NCGC00016467-01; NCGC00016467-02; NCGC00016467-03; NCGC00016467-04; NCGC00016467-05; NCGC00016467-06; NCGC00016467-07; NCGC00016467-08; NCGC00016467-11; NCGC00016467-12; NCGC00016467-21; NCGC00142375-01; NCGC00142375-02; NCGC00142375-03; NCGC00179375-01; NCGC00179375-02; CAS-491-70-3; ST024703; SY030155; CS-0694839; L8377; NS00015143; SW196433-3; C01514; L 9283; S00110; EN300-1659559; AM-721/20737006; F079506; Luteolin, primary pharmaceutical reference standard; Q415011; SR-01000779333-4; SR-01000779333-5; SR-01000779333-7; 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-chromenone; BRD-K05236810-001-05-9; BRD-K05236810-001-19-0; 23A002A4-B47B-46CD-848C-65042EACF3FF; Z1741977179; 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4H-benzopyrone-4-one; 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4H-chromen-4-one #; 4H-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-; Luteolin (Digitoflavone; Daphneflavonol; Flavopurpol; Luteolol)동의어